TY  - GEN
AU  - Penalver, Francisco-Javier
AU  - Marquez, Jose-Antonio
AU  - Duran, Soledad
AU  - Giraldo, Pilar
AU  - Martin, Alejandro
AU  - Montalban, Carlos
AU  - Sancho, Juan-Manuel
AU  - Ramirez, Maria-Jose
AU  - Terol, Maria-Jose
AU  - Capote, Francisco-Javier
AU  - Gutierrez, Antonio
AU  - Sanchez, Blanca
AU  - Lopez, Andres
AU  - Salar, Antonio
AU  - Rodriguez-Caravaca, Gil
AU  - Canales, Miguel
AU  - Caballero, Maria Dolores
AU  - Bello Lopez, Jose Luis
AU  - Carbonell, Felix
AU  - Ferrer Bordas, Secundino
AU  - Font Lopez, Patricia
AU  - Perez Persona, Ernesto
AU  - Lopez Guillermo, Armando
AU  - Hernandez Martin, Roberto
AU  - Ramon Mayans, Jose
AU  - Palomera, Luis
AU  - Perez Ceballos, Elena
AU  - Queizan Hernandez, Jose Antonio
AU  - Riaza Grau, Rosalia
AU  - de la Cruz, Fatima
AU  - Sanchez Salinas, Andres
AU  - GELTAMO (The Spanish Lymphoma Cooperative Group)
PY  - 2019
DO  - 10.1002/cam4.2555
SN  - 2045-7634
UR  - https://hdl.handle.net/20.500.12105/22831
AB  - Background: Consensus is lacking regarding the optimal salvage therapy for patients with follicular lymphoma who relapse after or are refractory to immunochemotherapy. Methods This phase II trial evaluated the efficacy and safety of response-adapted...
LA  - eng
PB  - Wiley
KW  - Bendamustine
KW  - Follicular lymphoma
KW  - Immunochemotherapy
KW  - Refractory
KW  - Relapsed
KW  - Aged
KW  - Adult
KW  - Humans
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - Mitoxantrone
KW  - Progression-Free Survival
KW  - Antineoplastic Agents
KW  - Middle Aged
KW  - Lymphoma, Follicular
KW  - Rituximab
KW  - Immunotherapy
KW  - Male
KW  - Neoplasm Recurrence, Local
KW  - Salvage Therapy
KW  - Female
KW  - Drug Resistance, Neoplasm
KW  - Dexamethasone
KW  - Bendamustine Hydrochloride
TI  - Response-adapted treatment with rituximab, bendamustine, mitoxantrone, and dexamethasone followed by rituximab maintenance in patients with relapsed or refractory follicular lymphoma after first-line immunochemotherapy: Results of the RBMDGELTAMO08 phase II trial
TY  - research article
ER  -